CNN: власти США планируют обвинить Россию во вмешательстве в выборы
Гендиректор ГПМ Радио заявил о хорошем времени для консолидации рынка
Москвичи стали реже парковать автомобили на газонах
В Малом театре рассказали о состоянии Валерия Афанасьева
Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma's Canadian subsidiary has acquired 40 million shares in eGenesis Inc. for USD 8 million. eGenesis is a biotechnology company developing human-compatible organs for transplant through xenotransplantation. This investment aims to support eGenesis' pioneering work in kidney, liver, and heart transplants, potentially addressing the global transplant shortage.
Risk of Rain 2 creators weigh in on Gearbox's first DLC without them: 'It's great to see new content for the game, but it's hard to see growing pains of the new team in real time'